Pharmaceutical company in India

id - 239
icon
India
Pharmaceuticals
Views: 261
  • Pharmaceutical company in India
  • Pharmaceutical company in India
    Pharmaceutical company in India
  • Revenue (year) 306,500,000 $
    23,871,905,750 ₽
    Profit (year) 87,500,000 $
    6,814,981,250 ₽
    Payback (mon.)
    Description

    Multinational pharmaceutical company headquartered in India is for sale. It is one of the leading generic pharmaceutical companies in Asia, it operates in more than 30 countries and has a diverse portfolio of products ranging from prescription drugs to over-the-counter medications and active pharmaceutical ingredients.

    The company is known for its strong research and development capabilities and has a reputation for manufacturing high-quality and affordable medicines. The company is committed to improving access to healthcare globally and strives to make a positive impact on people’s lives through its innovative products and sustainable practices.

    Currently the company do mostly private label, do not commercialize its own brand, but manufacture most of the common pharmaceutical forms (syrups, capsules, tablets, powders, lotions, solutions etc.).

    Keypoints:

    • Focused on manufacturing and marketing generic drugs, active pharmaceutical ingredients (APIs), and custom pharmaceutical services.
    • The company has a diverse portfolio of products spanning various therapeutic categories, including cardiovascular, neurology, gastrointestinal, dermatology, and oncology.
    • Global presence and operates in more than 30 countries worldwide.
    • Strong focus on research and development, investing a significant portion of its revenues in R&D activities.
    • Dedicated team of scientists and researchers who work on developing new drug formulations and improving existing ones.
    • Robust pipeline of new products, with several filings and approvals in various countries.
    • Known for its emphasis on quality and compliance with international regulatory standards.
    • Several manufacturing facilities in India and abroad, which adhere to good manufacturing practices (GMP) guidelines.
    • Strong track record of successfully launching and marketing generic versions of blockbuster drugs globally.
    • Established partnerships and collaborations with leading pharmaceutical companies to access new molecules and markets.

    All the property, equipment and real estate are included to the price.

    To obtain the details, the potential buyer must sign the NDA and send the POF.

    The information in the catalog is not an exact offer. The parameters of the deal are specified during negotiations with the seller.

    To perform this action, you must log in or register on the site.
    Start negotiation
    Price
    1,050,000,000 $
    81,779,775,000 ₽
    To perform this action, you must log in or register on the site.
    Start negotiation
    icon Useful tip

    Looking for ideas on which businesses to invest in and in which markets it is profitable to buy a ready-made business? The REAB website has useful articles in the topic of "Market and Investment Niche Reviews".

    Similar adverts
    icon
    India
    Pharmaceutical manufacturing business in India Pharmaceutical manufacturing business in India
    Revenue (year)
    25,000,000 $
    1,975,070,000 ₽
    Profit (year)
    3,000,000 $
    237,008,400 ₽
    Payback (mon.)
    Price
    40,000,000 $
    3,160,112,000 ₽
    icon
    India
    Pharmaceutical manufacturing company in India Pharmaceutical manufacturing company in India
    Revenue (year)
    1,900,000 $
    149,687,890 ₽
    Profit (year)
    No data
    Payback (mon.)
    Price
    12,000,000 $
    945,397,200 ₽
    icon
    Kyrgyzstan
    Medicine production plant in Kyrgyzstan Medicine production plant in Kyrgyzstan
    Audit done
    Revenue (year)
    No data
    Profit (year)
    No data
    Payback (mon.)
    Price
    6,000,000 €
    546,720,600 ₽
    Currency rates calculator
    Contact REAB
    Contact REAB
    Messengers for this number